China’s NHC: Coronavirus death toll rises to 361, confirmed cases 17,205
|Amid a slew of measures announced by the Chinese authorities to combat the negative impact of the coronavirus outbreak on the country’s economic growth, the National Health Commission (NHC) came out with the updated statistics on the virus epidemic.
Key Details (via Reuters):
The total number of deaths in China rose to 361 as of Sunday, up 57 from the previous day.
56 of the new deaths were in Hubei province, and one in the municipality of Chongqing.
The number of new confirmed infections in China rose by 2,829 on Sunday, bringing the total to 17,205.
The only good news is growth rate of the discharged patients is the highest.
Market Implications
The risk aversion remains a key theme across the Asian equity markets, with the Chinese stocks down nearly 8% so far this Monday on rising coronavirus risks. However, a sense of calm prevails across the fx board, as investors assess the implications of the Chinese focused policies announced earlier today.
USD/JPY trades firmer above 108.50 while the Antipodeans weigh in the downbeat Chinese macro news and Yuan sell-off. S&P 500 futures jump 0.70% while the US Treasury yields recover Friday’s steep declines.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.